Yashoda Hospitals, Hitec City has successfully performed a complex double lung transplant on a 47-year-old patient diagnosed with Anti-synthetase Syndrome-associated Fibrotic Interstitial Lung Disease (ILD), offering him a new lease on life after two years of oxygen dependence. The successful procedure further strengthens the hospital's position as a leading centre for advanced lung transplant surgery in Hyderabad and the management of complex end-stage lung diseases.
The patient had been living with progressive fibrotic ILD, a condition that causes irreversible scarring of the lungs, leading to severe respiratory failure. Despite receiving optimal medical treatment, his lung function continued to decline, leaving him dependent on long-term oxygen therapy. Following a comprehensive evaluation, a bilateral (double) lung transplant was identified as the only definitive treatment to restore his breathing and quality of life.
The transplant was successfully carried out by a multidisciplinary team led by Dr. V. Nagarjuna Maturu, Clinical Director, Department of Pulmonology, along with Dr. Manjunath Bale, Lung Transplant Surgeon, Dr. Vikram Reddy, Consultant Cardiothoracic and Vascular Surgeon (CTVS), Dr. Battu Chaithanya, Transplant Pulmonologist, and Dr. Sushanth Panda, Transplant Anaesthetist. The patient's perioperative and postoperative care was overseen by the Critical Care team under Dr. Ravi Shankar, with invaluable support from transplant nurses, physiotherapists, dietitians, and transplant coordinators.
The surgery was completed successfully without any intraoperative or postoperative complications. Following the transplant, the patient was gradually weaned off oxygen support, regained functional independence, and was able to walk comfortably before discharge. His remarkable recovery enabled him to return home just 10 days after the procedure.
Speaking on the successful transplant, Dr. V. Nagarjuna Maturu, Clinical Director, Department of Pulmonology, Yashoda Hospitals, Hitec City, said:
"Patients with Anti-synthetase Syndrome-associated Fibrotic Interstitial Lung Disease often experience relentless progression of lung fibrosis, eventually leading to end-stage respiratory failure. For carefully selected patients, lung transplantation offers the opportunity to breathe independently again and regain a meaningful quality of life. This successful outcome highlights the importance of early referral, timely evaluation, meticulous patient selection, and coordinated multidisciplinary care. Witnessing the patient walk independently and breathe without oxygen within days of surgery is truly rewarding for the entire team."
